Helicobacter pylori infection and arterial stiffness in patients with type 2 diabetes mellitus. 2008

Masayoshi Ohnishi, and Michiaki Fukui, and Takeshi Ishikawa, and Nahoko Ohnishi, and Noriko Ishigami, and Keiji Yoshioka, and Goji Hasegawa, and Toshikazu Yoshikawa, and Naoto Nakamura
Department of Diabetes and Endocrinology, Matsushita Memorial Hospital, Osaka 570-0096, Japan.

Epidemiologic studies have suggested possible atherogenic roles for such pathogens as Chlamydia pneumoniae, Helicobacter pylori (Hp), cytomegalovirus, and herpes simplex virus. The aim of the present study was to examine the relationship between seropositivity of antibodies to Hp (Hp infection) and arterial stiffness determined by pulse wave velocity (PWV) in 130 patients (73 men and 57 women) with type 2 diabetes mellitus without a history of cardiovascular disease. The prevalence of Hp infection in patients with type 2 diabetes mellitus was 53.8%. Age (66.7 +/- 11.3 vs 60.0 +/- 12.2 years, P = .0014) and systolic blood pressure (138 +/- 19 vs 131 +/- 22 mm Hg, P = .0420) were significantly higher in patients with Hp infection than in those without. Serum C-reactive protein was higher in patients with Hp infection than in those without, although it did not reach statistical significance (0.23 +/- 0.27 vs 0.18 +/- 0.20 mg/dL, P = .2205). Pulse wave velocity was significantly higher in patients with Hp infection than in those without (1877 +/- 550 vs 1585 +/- 331 cm/s, P = .0005). Multiple regression analysis demonstrated that age (beta = .388, P < .0001), mean arterial pressure (beta = .289, P = .0006), hypertensive treatment (beta = .185, P = .0282), and presence of Hp infection (beta = .169, P = .0220) were independent determinants of PWV. In conclusion, Hp infection is associated with arterial stiffness determined by PWV in patients with type 2 diabetes mellitus.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Masayoshi Ohnishi, and Michiaki Fukui, and Takeshi Ishikawa, and Nahoko Ohnishi, and Noriko Ishigami, and Keiji Yoshioka, and Goji Hasegawa, and Toshikazu Yoshikawa, and Naoto Nakamura
February 2015, Diabetes technology & therapeutics,
Masayoshi Ohnishi, and Michiaki Fukui, and Takeshi Ishikawa, and Nahoko Ohnishi, and Noriko Ishigami, and Keiji Yoshioka, and Goji Hasegawa, and Toshikazu Yoshikawa, and Naoto Nakamura
December 2007, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology,
Masayoshi Ohnishi, and Michiaki Fukui, and Takeshi Ishikawa, and Nahoko Ohnishi, and Noriko Ishigami, and Keiji Yoshioka, and Goji Hasegawa, and Toshikazu Yoshikawa, and Naoto Nakamura
January 2003, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
Masayoshi Ohnishi, and Michiaki Fukui, and Takeshi Ishikawa, and Nahoko Ohnishi, and Noriko Ishigami, and Keiji Yoshioka, and Goji Hasegawa, and Toshikazu Yoshikawa, and Naoto Nakamura
January 2020, Advanced biomedical research,
Masayoshi Ohnishi, and Michiaki Fukui, and Takeshi Ishikawa, and Nahoko Ohnishi, and Noriko Ishigami, and Keiji Yoshioka, and Goji Hasegawa, and Toshikazu Yoshikawa, and Naoto Nakamura
January 2019, Advanced biomedical research,
Masayoshi Ohnishi, and Michiaki Fukui, and Takeshi Ishikawa, and Nahoko Ohnishi, and Noriko Ishigami, and Keiji Yoshioka, and Goji Hasegawa, and Toshikazu Yoshikawa, and Naoto Nakamura
April 2018, Diabetes care,
Masayoshi Ohnishi, and Michiaki Fukui, and Takeshi Ishikawa, and Nahoko Ohnishi, and Noriko Ishigami, and Keiji Yoshioka, and Goji Hasegawa, and Toshikazu Yoshikawa, and Naoto Nakamura
April 2011, Journal of diabetes investigation,
Masayoshi Ohnishi, and Michiaki Fukui, and Takeshi Ishikawa, and Nahoko Ohnishi, and Noriko Ishigami, and Keiji Yoshioka, and Goji Hasegawa, and Toshikazu Yoshikawa, and Naoto Nakamura
March 2019, Minerva gastroenterologica e dietologica,
Masayoshi Ohnishi, and Michiaki Fukui, and Takeshi Ishikawa, and Nahoko Ohnishi, and Noriko Ishigami, and Keiji Yoshioka, and Goji Hasegawa, and Toshikazu Yoshikawa, and Naoto Nakamura
June 2020, Journal of diabetes and metabolic disorders,
Masayoshi Ohnishi, and Michiaki Fukui, and Takeshi Ishikawa, and Nahoko Ohnishi, and Noriko Ishigami, and Keiji Yoshioka, and Goji Hasegawa, and Toshikazu Yoshikawa, and Naoto Nakamura
January 2020, Diabetes & vascular disease research,
Copied contents to your clipboard!